Matsumura M, Atkinson J B, Hays D M, Hammond G D, Siegel S E, Sather H, Grosfeld J, Haase G
Children's Cancer Study Group, Pasadena, CA.
J Pediatr Surg. 1988 May;23(5):448-53. doi: 10.1016/s0022-3468(88)80446-9.
The role of surgery was evaluated in 320 patients with metastatic neuroblastoma (Children's Cancer Study Group [CCSG] stage IV, excluding IV-S) enrolled in two CCSG treatment protocols between June 1978 and November 1982. The regimens consisted of combination chemotherapy, radiation therapy, and surgery. Two hundred seventy-seven surgical procedures were performed in 214 of the 320 eligible patients. Surgical intervention at the primary site was performed at initiation of therapy in 86 patients. There was a slight survival advantage when complete resection of the primary tumor was achieved (P = .09). Delayed surgery was performed in 89 patients. Gross complete resection of primary tumor was feasible in 57 of these patients (64.0%). However, survival analysis showed that resolution of metastases had a more important impact on subsequent length of survival than resectability at the delayed procedure (P = .005).
1978年6月至1982年11月期间,在两项儿童癌症研究组(CCSG)治疗方案中,对320例转移性神经母细胞瘤患者(CCSG IV期,不包括IV-S期)的手术作用进行了评估。治疗方案包括联合化疗、放疗和手术。320例符合条件的患者中有214例进行了277次手术。86例患者在治疗开始时对原发部位进行了手术干预。当原发肿瘤实现完全切除时,有轻微的生存优势(P = 0.09)。89例患者进行了延迟手术。其中57例患者(64.0%)可行原发肿瘤大体完全切除。然而,生存分析表明,转移灶的消退对随后的生存时间影响比延迟手术时的可切除性更重要(P = 0.005)。